Clinical Trial Update: LEPU Renal Denervation System for Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the LEPU Renal Denervation System for resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension
• Vascular Disease

Drugs mentioned

• LEPU Renal Denervation System (Renal denervation system)

Snippet

Sponsor: Lepu Medical Technology (Beijing) Co., Ltd. | Conditions: Hypertension, Cardiovascular Diseases | Phase 3 | Status: COMPLETED